Abstract
Introduction

Percutaneous renal revascularization with stenting is generally effective for improving hypertension, and stabilizing renal failure in a substantial percentage of patients, and in eliminating recurrent cardiac events in patients with atherosclerotic renal artery stenosis (1, 2). However, chronic total occlusion of a renal artery supplying a small atrophied kidney had not been considered an appropriate target for intervention because renal artery revascularization would not be expected to improve hypertension and renal function (3).
The present case indicates that an atrophied kidney can be hormonally active, and therefore contribute to significant hypertension. Furthermore, the occlusion of the ostial portion of the renal artery was a complex lesion for percutaneous renal revascularization. This report demonstrates that the recanalization of a chronically occluded renal artery may result in the restoration of the renal function.
Case Report
The patient was a 57-year-old man with a past history of dyslipidemia, arteriosclerosis obliterans and tobacco use. In March 2006, he 
-Mu l t i -d e t e c t o r r o w c o mp u t e d t o mo g r a p h y ( MDCT ) . MDCT s h o ws t o t a l o c c l u s i o n o f t h e l e f t r e n a l a r t e r y ( b l a c k a r r o w) .
T h e l e f t r e n a l a r t e r y wa s l o c a t e d l o we r t h a n t h e r i g h t r e n a l a r t e r y a n d t h e u p p e r o f t h e t h i r d v e r t e b r a e l u mb a l e s ( A) . T h e a b d o mi n a l a o r t a a n d l e f t r e n a l a rt e r y a n g u l a t i o n s we r e 2 5 º ( B ) . A s ma l l c o l l a t e r a l v e s s e l s u p p l y i n g t h e l e f t k i d n e y ma y h a v e b e e n a b r a n c h o f t h e s u p e r i o r me s e n t e r i c a r t e r y ( wh i t e a r r o w) . Abdominal aortography showed a total occlusion of the ostium of the renal artery ( Fig. 2A) (Fig. 2B) . The total occluded lesion was crossed with a 0.018 inch Neo's treasure guidewire (Asahi Intec Corp., Tokyo, Japan). However, the microcatheter did not pass through (Fig. 2C) (Fig. 2E) . The stent deployed at 12 atm without complications and showed the restoration of renal flow (Fig. 2F) Renal MDCT showed a patent left renal stent two years after the index procedure (Fig. 3) Figure 4 shows h e r o s c l e r o t i c r e n o v a s c u l a r d i s e a s e s h o we d c h r o n i c  k i d n e y d i s e a s e a n d r e f r a c t o r y h y p e r t e n s i o n . He t o o k f o u r a n t i h y p e r t e n s i v e d r u g s . Af t e r p e r c u t a n eo u s r e n a l r e v a s c u l a r i z a t i o n ( P T RA) , h i s r e n a l f u n c t i o n wa s s t a b i l i z e d a n d t h e p r o t e i n u r i a h a d  d i s a p p e a r e d . He wa s a d mi n i s t e r e d a s i n g l e a n t i h y p e r t e n s i v e d r u g ( e n a l a p r i l 2 . 5 mg d a i l y ) . T h e p at i e n t wa s p r e s e n t l y d o i n g we l l wi t h a s u f f i c i e n t l y c o n t r o l l e d b l o o d p r e s s u r e a t t h e 3 -y e a r f o l l o w-u 
. However, it was impossible to confirm the ostial part and distal part of left renal artery. The position of the left renal artery was determined using MDCT. The left renal artery was located at the lower portion of the right renal artery and the upper portion of the third vertebrae lumbales (Fig. 1A). The abdominal aorta and left renal artery angulations were 25°(Fig. 1B). This indicated that this part was the ostial part of the left renal artery. An image intensifier was angulated into a left anterior oblique view at 25°. An 8 Fr RDC(I) guiding catheter was positioned at the ostial part of the left renal artery using the aorta no touch technique
F i g u r e 2 . P e r c u t a n e o u s r e n a l r e v a s c u l a r i z a t i o n . Ab d o mi n a l a o r t o g r a p h y s h o we d t o t a l o c c l u s i o n o f t h e o s t i u m o f t h e l e f t r e n a l a r t e r y ( A) . An i ma g e i n t e n s i f i e r wa s a n g u l a t e d t o a l e f t a n t e r i o r o b l i q u e v i e w o f 2 5 º . An 8 F r RDC( I ) g u i d i n g c a t h e t e r wa s p o s i t i o n e d a t t h e l e f t r e n a l a r t e r y o s t i a l p a r t u s i n g t h e a o r t a n o t o u c h t e c h n i q u e ( B ) . T h e t o t a l o c c l u d e d l e s i o n wa s c r o s s e d wi t h a 0 . 0 1 8 i n c h Ne o ' s t r e a s u r e g u i d e wi r e . Ho we v e r , t h e mi c r o c a t h e t e r wa s n o t p a s s e d ( C) . T h e r e f o r e , a 0 . 0 1 4 i n c h Ne o ' s s o f t g u i d e wi r e wa s p a s s e d i n t o t h e d i s t a l t r u e c h a n n e l u s i n g t h e p a r a l l e l wi r e t e c h n i q u e a n d p r e d i l a t i o n wi t h a 1 . 5 mm b a l l o o n ( D) . F u r t h e r d i l a t i o n wa s p e r f o r me d wi t h a 4 mm b a l l o o n a t 7 a t m. A P a l ma t z 6 . 0 × 1 8 mm s t e n t wa s p o s i t i o n e d a t t h e o s t i a l l e s i o n e n s u r i n g t h a t t h e p r o x i ma l ma r k e r o f t h e s t e n t wa s p r o t r u d i n g p r e c i s e l y p r o x i ma l l y i n t h e r e n a l a r t e r y ( E ) . T h e s t e n t d e p l o y e d a t 1 2 a t m wi t h o u t c o mp l i c a t i o n s a n d s h o we d t h e r e s t o r a t i o n o f r e n a l f l o w ( F ) . S MA: s u p e r i o r me s e n t e r i c a r t e r y mg, aspirine 100 mg and ticropidine 200 mg daily after discharge.
Discussion
Renal artery stenting has emerged as a safe therapy for both unilateral and bilateral renal artery stenosis and is indicated for refractory hypertension, especially when it is associated with congestive heart failure (2, 4). Numerous studies have demonstrated low restenosis rates and have shown some improvement in the blood pressure control (2-4) as well as improvement or stabilization of creatinine clearance (4-6), while risks have included cholesterol embolization, progression of renal disease and bleeding (2, 4). However, the benefits and long patency after renal artery stenting have not yet been determined for chronic total occlusion of a renal artery supplying a small atrophied kidney. Alhadad et al reported sustained beneficial effects on blood pressure over a long (mean 2.6 years) follow-up after percutaneous renal revascularization of renal artery occlusion without atrophied kidney (7). In their article, it was reported that revascularization was not attempted in patients with atrophied kidney (renal size <7 cm). Wykrzykowska et al reported renal artery stenting for a total occlusion in a patient without atrophied kidney (8.4 cm of affected kidney size) that maintained a patent renal stent for 5 months after the procedure (8). The current case showed a longer period of a patent renal stent and improvement of hypertension over three
F i g u r e 3 . 1 6 -Mu l t i -d e t e c t o r r o w c o mp u t e d t o mo g r a p h y ( MDCT ) a f t e r p e r c u t a n e o u s r e n a l r e v a s c u l a r i z a t i o n . Re n a l MDCT s h o we d a p a t e n t l e f t r e n a l s t e n t a f t e r 2 y e a r s .
F i g u r e 4 . T h e c l i n i c a l c o u r s e o f t h e p a t i e n t . At
